HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Earnings    EPS Surprises    Mutual Funds    Options    My Account    Help    

Zacks Mutual Fund Rank
Did you know that Zacks now ranks mutual funds? We've reinvented the way mutual funds are rated.   Try it now.
Quote:
Login Free Membership
Search:

Top Zacks Features
Free Membership
Premium Home
Zacks Rank
Equity Research
My Portfolio
Stock Screener
Profit Tracks
Mutual Funds
Options
Zacks Video
RSS Feed
Profit from the Pros

Subscription Services
Top 10 Stocks
Product Guide
Zacks Premium
Zacks Elite
Method for Trading
Chart Patterns Trader
Double Your Money
ETF Trader
Growth Trader
Options Trader
Small Cap Trader
Strategic Investor
Surprise Trader
Value Trader
Special Reports
Research Wizard

Zacks Premium
Get profitable stock
picks and timely
market advice in
Zacks.com`s Free
Daily Newsletter!

Free Registration

View the Archive


PFE: Pfizer Inc - Stock Quote Enter Ticker:
 

QuoteEstimatesCharts Company ReportsNewsFinancials
  Quote |  Detailed Quotes |  Real Time |  Options Chain |  Greeks Montage

PFIZER INC (NYSE)
PFE 17.88 N/A (N/A%) Vol.  240 N/A ET

Day Low - High N/A - N/A
52wk Low - High 11.62 - 20.36
Avg Volume 60,671,596
Industry LARGE CAP PHARMA
Market Cap 143.96 B
Div - Yield 0.72 - 4.04
PE (forward) 8.14
PEG Ratio 4.42
Current Year Est. 2.19
EPS Last Year 2.02
Detailed Quote


Premium Research: Stock Analysis

Zacks Rank

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Zacks Rank Definition Annualized Return
# 1Buy12%
# 2Strong Sell50.23%
# 3Hold14%
# 4Sell3.97%
# 5Hold1.85%
S&P50012.22%
Zacks Rank Education - Learn more about the Zacks Rank
Zacks Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank


downgraded 01/20/2010
Short-Term Rating 1-3 Months
PREMIUM
Zacks Recommendation

Zacks Recommendations are an excellent predictor of stock price movement over a 6+ month time frame. The recommendations come from the Zacks Equity Research group which combines the Zacks Rank with the insights from their team of over 50 equity analysts. The result is superior long term stock ratings.

The Zacks Recommendations are split into 3 groups: Outperform, Neutral and Underperform. When Zacks Premium members click on the recommendation it will launch them to the Zacks Equity Research report for the stock. More on these reports below.

Difference Between Zacks Rank and Zacks Recommendation
Zacks Equity Research Home
Zacks Premium - The only way to get access to Zacks Recommendations


Long-Term Rating 6+ Months
PREMIUM
Zacks Industry Rank

Which industries are set to outperform or underperform the market? You'll find the answer here. We have broken down all industries into over 200 classifications. Then ranked these industries using the most powerful indicator we know (the Zacks Rank). The higher the industry rank, the better the industry should perform in the future. Once you have found an attractive industry then check out the Rank in Industry to find the best stocks within the industry.

When Zacks Premium members click on the Zacks Industry Rank link they will see the full listing of industries and their current rankings.

About Zacks Industry Rank
Zacks Industry Rank - All current industry ranks.
Zacks Premium - The only way to get access to the Zacks Industry Rank

PREMIUM
Target Price

The Zacks Price Target provides you our expectation for a stocks share price in the next 6 months. These price targets are created by the Zacks Equity Research group to coincide with their recommendations that are also based on a 6 month time horizon.

Zacks Equity Research Home
Zacks Premium - The only way to get access to the Zacks Price Targets

PREMIUM
Equity Research Report

The Zacks Recommendations and Zacks Target Prices are just two of the valuable resources you'll find in the reports created by the Zacks Equity Research group. When Zacks Premium members click on this link they will taken to a page that gives them access to the Zacks Equity Research report for the stock.

Zacks Equity Research Home Zacks Premium - The only way to get access to Zacks Recommendations


Updated as of 02/05/2010
PREMIUM
Get all our stock ratings and recommendations with a Free Trial to Zacks Premium

Premium Research: Industry Analysis

Top Peers Ticker Zacks Rank
PFIZER INC PFE PREMIUM
ALCON INC ACL PREMIUM
ABBOTT LABS ABT PREMIUM
ALLERGAN INC AGN PREMIUM
See all LARGE CAP PHARMA Peers

BROKERAGE RECOMMENDATIONS
Current ABR 1.61
ABR (Last Week) 1.61
# of Recs in ABR 19
Average Target Price 21.90
Industry Rank by ABR 136 out of 217
Rank in Industry 2 out of 15
More Brokerage Recommendations

Zacks Community PeopleAndPicks.com
Community Rating

PeopleAndPicks.com Community Stock Ratings

Rating Recommendation % of Stocks
5 stars Strong Buy 10%
4 stars Buy 20%
3 stars Hold 40%
2 stars Sell 20%
1 stars Strong Sell 10%
0 stars Not Rated  

We believe that a community of investors working together can create a superior stock rating system. Some call this "collective intelligence". Or simply...together we can beat the market!

A stock's Community Rating is calculated based on the aggregate input of the PeopleAndPicks Community. The proportion of buy to sell ratings, recency of analysis, and the average score of the users who rate it favorably all factor into a score of one to five stars.


How do you rate PFE?
Buy
Sell
Find out what the Zacks Community
thinks of PFE at PeopleAndPicks.com

NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.

 Interactive Java Charting
 Comparative Chart



 
ZACKS COMMENTARY FOR PFE
Zacks Blog: Label Expansion for AZN Drug
Feb 09, 2010
Zacks Blog: Stock Market News for February 8, 2010
Feb 08, 2010
Zacks Equity Research: Report for PFE
Feb 05, 2010
Zacks Blog: Stock Market News for February 4, 2010
Feb 04, 2010
Zacks Blog: Zacks Analyst Blog Highlights: Time Warner Inc., AOL, Time Warner Cable, News Corporation and Pfizer Inc.
Feb 04, 2010
Zacks Blog: FDA Approves Auxilium’s Xiaflex
Feb 03, 2010
Zacks Blog: Pfizer In-Line, Guidance Down
Feb 03, 2010
Zacks Blog: Company News for February 3, 2010
Feb 03, 2010
More Zacks Commentary
NEWS
Pfizer (PFE) Trading Just Under Resistance Level With Bearish Technicals
Feb 08, 2010
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
Feb 08, 2010
ABN Newswire Stocks to Watch: February 8, 2010
Feb 07, 2010
Germany: QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
Feb 07, 2010
Weekly Market Wrap: February 5, 2010
Feb 05, 2010
QIAGEN Unit and Pfizer sign partnership agreement for brain tumour companion diagnostic kit
Feb 05, 2010
Pfizer and QIAGEN's DxS to develop companion diagnostic for brain tumour patients
Feb 05, 2010
Benitec Limited (ASX:BLT) Licensee Achieves Significant Milestone With Pfizer (NYSE:PFE)
Feb 04, 2010
More News
EARNINGS ESTIMATES
  This Quarter
03/2010
Next Quarter
06/2010
This Year
12/2010
Next Year
12/2011
Average Estimate 0.54 0.55 2.20 2.35
Number of Estimates 14 13 15 14
Low Estimates 0.49 0.51 2.13 2.23
High Estimate 0.62 0.58 2.40 2.49
Year Ago EPS 0.54 0.48 2.02 2.20
EPS Growth 0.66% 14.26% 8.84% 6.85%

More Estimates

COMPANY DESCRIPTION
Pfizer Inc is a research-based, global pharmaceutical company that discovers and develops innovative, value-added products that improve the quality of life of people around the world and help them enjoy longer, healthier, and more productive lives. Pfizer has three business segments: health care, animal health and consumer health care. Its products are available in numerous countries. (Company Press Release)

Full Company Report
FINANCIALS
EPS TTM 2.02
Sales 50009
Net Income 8635
Price/Earnings 8.83
Price/Book 1.82
Price/Cash Flow 5.61
Price/Sales 2.88


More Financials

 
About Zacks | Advertise | Affiliate | Media | Careers | Contact Us | Help
Disclaimer | Privacy Policy | Sitemap
NYSE and AMEX data is at least 20 minutes delayed.  NASDAQ data is at least 15 minutes delayed.
Copyright 2010 Zacks Investment Research